These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 23107940)

  • 21. A comparative study of top-down and bottom-up approaches for the preparation of micro/nanosuspensions.
    Verma S; Gokhale R; Burgess DJ
    Int J Pharm; 2009 Oct; 380(1-2):216-22. PubMed ID: 19596059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glabridin nanosuspension for enhanced skin penetration: formulation optimization, in vitro and in vivo evaluation.
    Wang WP; Hul J; Sui H; Zhao YS; Feng J; Liu C
    Pharmazie; 2016 May; 71(5):252-7. PubMed ID: 27348968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation of ritonavir nanosuspensions by microfluidization using polymeric stabilizers: I. A Design of Experiment approach.
    Karakucuk A; Celebi N; Teksin ZS
    Eur J Pharm Sci; 2016 Dec; 95():111-121. PubMed ID: 27181836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and in vitro evaluation of deacety mycoepoxydiene nanosuspension.
    Wang Y; Liu Z; Zhang D; Gao X; Zhang X; Duan C; Jia L; Feng F; Huang Y; Shen Y; Zhang Q
    Colloids Surf B Biointerfaces; 2011 Apr; 83(2):189-97. PubMed ID: 21176876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and evaluation of PIK75 nanosuspension, a phosphatidylinositol-3-kinase inhibitor.
    Talekar M; Kendall J; Denny W; Jamieson S; Garg S
    Eur J Pharm Sci; 2012 Dec; 47(5):824-33. PubMed ID: 23069617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of spray granulation for conversion of a nanosuspension into a dry powder form.
    Bose S; Schenck D; Ghosh I; Hollywood A; Maulit E; Ruegger C
    Eur J Pharm Sci; 2012 Aug; 47(1):35-43. PubMed ID: 22565066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Development of Silymarin nanocrystals lyophilized power applying nanosuspension technology].
    Zhao X; Wang G; Zhang B; Li H; Nie Q; Zang C; Zhao X
    Zhongguo Zhong Yao Za Zhi; 2009 Jun; 34(12):1503-8. PubMed ID: 19777833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanosuspension for the delivery of a poorly soluble anti-cancer kinase inhibitor.
    Danhier F; Ucakar B; Vanderhaegen ML; Brewster ME; Arien T; Préat V
    Eur J Pharm Biopharm; 2014 Sep; 88(1):252-60. PubMed ID: 24859391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Co-administration of a nanosuspension of a poorly soluble basic compound and a solution of a proton pump inhibitor--the importance of gastrointestinal pH and solubility for the in vivo exposure.
    Sigfridsson K; Lundqvist A; Strimfors M
    Drug Dev Ind Pharm; 2011 Sep; 37(9):1036-42. PubMed ID: 21417620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation of a nanosuspension stabilized by Soluplus® to improve bioavailability.
    Yang H; Teng F; Wang P; Tian B; Lin X; Hu X; Zhang L; Zhang K; Zhang Y; Tang X
    Int J Pharm; 2014 Dec; 477(1-2):88-95. PubMed ID: 25455766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigation of preparation parameters of nanosuspension by top-down media milling to improve the dissolution of poorly water-soluble glyburide.
    Singh SK; Srinivasan KK; Gowthamarajan K; Singare DS; Prakash D; Gaikwad NB
    Eur J Pharm Biopharm; 2011 Aug; 78(3):441-6. PubMed ID: 21439378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resveratrol nanosuspensions: interaction of preservatives with nanocrystal production.
    Kobierski S; Ofori-Kwakye K; Müller RH; Keck CM
    Pharmazie; 2011 Dec; 66(12):942-7. PubMed ID: 22312699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of PIK-75 nanosuspension formulation with enhanced delivery efficiency and cytotoxicity for targeted anti-cancer therapy.
    Talekar M; Ganta S; Amiji M; Jamieson S; Kendall J; Denny WA; Garg S
    Int J Pharm; 2013 Jun; 450(1-2):278-89. PubMed ID: 23632263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation and in vitro/in vivo evaluation of felodipine nanosuspension.
    Sahu BP; Das MK
    Eur J Drug Metab Pharmacokinet; 2014 Sep; 39(3):183-93. PubMed ID: 24198215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Practical method for preparing nanosuspension formulations for toxicology studies in the discovery stage: formulation optimization and in vitro/in vivo evaluation of nanosized poorly water-soluble compounds.
    Komasaka T; Fujimura H; Tagawa T; Sugiyama A; Kitano Y
    Chem Pharm Bull (Tokyo); 2014; 62(11):1073-82. PubMed ID: 25366311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Solid lipid nanoparticles and nanosuspension formulation of Saquinavir: preparation, characterization, pharmacokinetics and biodistribution studies.
    Dodiya SS; Chavhan SS; Sawant KK; Korde AG
    J Microencapsul; 2011; 28(6):515-27. PubMed ID: 21728760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determination of atropisomeric configurations of macrocyclic bisbibenzyls by HPLC-CD/UV and quantum chemical calculations.
    Wang LN; Xie CF; Zhu XS; Fan PH; Lou HX
    J Asian Nat Prod Res; 2011 Apr; 13(4):312-8. PubMed ID: 21462034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanosuspensions as advanced printing ink for accurate dosing of poorly soluble drugs in personalized medicines.
    Pardeike J; Strohmeier DM; Schrödl N; Voura C; Gruber M; Khinast JG; Zimmer A
    Int J Pharm; 2011 Nov; 420(1):93-100. PubMed ID: 21889582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Solution calorimetry as an alternative approach for dissolution testing of nanosuspensions.
    Kayaert P; Li B; Jimidar I; Rombaut P; Ahssini F; Van den Mooter G
    Eur J Pharm Biopharm; 2010 Nov; 76(3):507-13. PubMed ID: 20887787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of a nanoparticle formulation to investigate some hemodynamic parameters of a poorly soluble compound.
    Sigfridsson K; Björkman JA; Skantze P; Zachrisson H
    J Pharm Sci; 2011 Jun; 100(6):2194-202. PubMed ID: 21491443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.